Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 20, 2023
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
[ Mon, Nov 20th 2023
] - WOPRAI
Sun, November 19, 2023
[ Sun, Nov 19th 2023
] - WOPRAI
Fri, November 17, 2023
[ Fri, Nov 17th 2023
] - WOPRAI
[ Fri, Nov 17th 2023
] - WOPRAI
[ Fri, Nov 17th 2023
] - WOPRAI
[ Fri, Nov 17th 2023
] - WOPRAI
[ Fri, Nov 17th 2023
] - WOPRAI
Calvin Sternick Maintained (USPH) at Buy with Decreased Target to $99 on, Nov 17th, 2023
Calvin Sternick of JP Morgan, Maintained "U.S. Physical Therapy, Inc." (USPH) at Buy with Decreased Target from $108 to $99 on, Nov 17th, 2023.
Calvin has made no other calls on USPH in the last 4 months.
There are 2 other peers that have a rating on USPH. Out of the 2 peers that are also analyzing USPH, 0 agree with Calvin's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Calvin
- Michael Petusky of "Barrington Research" Maintained at Buy with Decreased Target to $111 on, Thursday, November 9th, 2023
- Larry Solow of "CJS Securities" Upgraded from Hold to Buy on, Tuesday, September 19th, 2023
